LUV.png
Love Pharma’s Acquisition Will Offer Exclusive Partnership and License with World Renowned University to Conduct Landmark Psilocybin Study
30 nov. 2021 08h50 HE | Love Pharma Inc.
NEW YORK, NY, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Love Pharma Inc. (CSE: LUV) (FSE: G1Q0) continues to prioritize the necessity for clinical validation as a vital step in bringing its products to...
eSight logo 2018.png
eSight Announces Clinical Research Partnership with Ocular Health Centre’s EyeStart Inc.
20 oct. 2021 09h00 HE | eSight
TORONTO, Oct. 20, 2021 (GLOBE NEWSWIRE) -- Leading vision-enhancement platform, eSight, today announces a new research and development partnership with the Ocular Health Centre, one of Ontario’s top...
Accuro Epidural Guidance
RIVANNA's Accuro Shows Statistically Significant Efficacy and Safety for Combined Spinal-Epidural Anesthesia
27 sept. 2021 06h00 HE | Rivanna Medical
CHARLOTTESVILLE, Va., Sept. 27, 2021 (GLOBE NEWSWIRE) -- RIVANNA®, developers of world-first, imaging-based medical solutions, today announced the results of a recent randomized controlled trial...
Aspero Medical announces patent award for their micro-texturing Pillar technology designed to improve outcomes of endoscopy procedures
17 août 2021 10h46 HE | Innosphere Ventures
Boulder, Colorado, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Aspero Medical, a medical device startup company developing new products for the field of gastroenterology, announced that the United States...
SPR Therapeutics LOGO 361 TM.jpg
Multi-Center Study of SPRINT® PNS System for Chronic Low Back Pain Demonstrates Clinically Significant Improvements in Pain and Quality of Life
12 juil. 2021 08h00 HE | SPR Therapeutics, Inc.
CLEVELAND, July 12, 2021 (GLOBE NEWSWIRE) -- In the largest, most rigorous study to date using the SPRINT® PNS System for chronic axial low back pain (LBP), patients that failed to find relief from...
SPR Therapeutics LOGO 361 TM.jpg
Multi-center Study Demonstrates Significant Reductions in Postoperative Pain and Opioid Use Following Peripheral Nerve Stimulation Treatment
26 avr. 2021 09h41 HE | SPR Therapeutics, Inc.
CLEVELAND, April 26, 2021 (GLOBE NEWSWIRE) -- Results of a multicenter trial recently published in Anesthesiology, the official peer-reviewed journal of the American Society of Anesthesiologists,...
SPR Therapeutics LOGO 361 TM.jpg
SPRINT® PNS System Demonstrates the Important Role of the Multifidus in Treating Recurrent Low Back Pain Following RFA
02 mars 2021 10h45 HE | SPR Therapeutics, Inc.
CLEVELAND, March 02, 2021 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, announced publication of clinical data evaluating the impact of...
Aspero Medical completes animal clinical study and announces the formation of Clinical Advisory Board
29 déc. 2020 10h24 HE | Innosphere Ventures
Boulder, Colorado, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Aspero Medical, a medical device startup focused on developing new products for the field of gastroenterology recently completed the company’s...
104566_GREYCLOAK.jpg
Grey Cloak Tech Inc. Announces Positive Results From a Clinical Study of Their Proprietary Womens HERHEART Product
03 déc. 2020 08h30 HE | Grey Cloak Tech Inc
LAS VEGAS, NV, Dec. 03, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – Grey Cloak Tech Inc. (OTCQB: GRCK) (soon to be Healthy Extracts Inc. pending their corporate name change), a company engaged in...
RenovaCare_FullLogo_RGB-full.png
RenovaCare Receives FDA Conditional IDE Approval of CellMist™ System and SkinGun™ Device, Enabling Clinical Study for Safety and Feasibility
11 août 2020 08h30 HE | RenovaCare, Inc.
ROSELAND, N.J., Aug. 11, 2020 (GLOBE NEWSWIRE) -- RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com), developer of patented technologies for spraying self-donated stem cells for the regeneration...